Copyright Reports & Markets. All rights reserved.

Global Synthetic Peptide Vaccine Market Research Report 2021

Request for Sample of this report
Buy now

1 Synthetic Peptide Vaccine Market Overview

  • 1.1 Product Overview and Scope of Synthetic Peptide Vaccine
  • 1.2 Synthetic Peptide Vaccine Segment by Type
    • 1.2.1 Global Synthetic Peptide Vaccine Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Solution Phase Synthesis (SPS)
    • 1.2.3 Solid Phase Peptide Synthesis (SPPS)
  • 1.3 Synthetic Peptide Vaccine Segment by Application
    • 1.3.1 Global Synthetic Peptide Vaccine Sales Comparison by Application: (2021-2027)
    • 1.3.2 Prostate Cancer
    • 1.3.3 Breast Cancer
    • 1.3.4 Gastric Cancer
    • 1.3.5 Lung Cancer
    • 1.3.6 Pancreatic Cancer
    • 1.3.7 Others
  • 1.4 Global Synthetic Peptide Vaccine Market Size Estimates and Forecasts
    • 1.4.1 Global Synthetic Peptide Vaccine Revenue 2016-2027
    • 1.4.2 Global Synthetic Peptide Vaccine Sales 2016-2027
    • 1.4.3 Synthetic Peptide Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Synthetic Peptide Vaccine Market Competition by Manufacturers

  • 2.1 Global Synthetic Peptide Vaccine Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Synthetic Peptide Vaccine Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Synthetic Peptide Vaccine Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Synthetic Peptide Vaccine Manufacturing Sites, Area Served, Product Type
  • 2.5 Synthetic Peptide Vaccine Market Competitive Situation and Trends
    • 2.5.1 Synthetic Peptide Vaccine Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Synthetic Peptide Vaccine Players Market Share by Revenue
    • 2.5.3 Global Synthetic Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Synthetic Peptide Vaccine Retrospective Market Scenario by Region

  • 3.1 Global Synthetic Peptide Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Synthetic Peptide Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Synthetic Peptide Vaccine Market Facts & Figures by Country
    • 3.3.1 North America Synthetic Peptide Vaccine Sales by Country
    • 3.3.2 North America Synthetic Peptide Vaccine Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Synthetic Peptide Vaccine Market Facts & Figures by Country
    • 3.4.1 Europe Synthetic Peptide Vaccine Sales by Country
    • 3.4.2 Europe Synthetic Peptide Vaccine Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Synthetic Peptide Vaccine Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Synthetic Peptide Vaccine Sales by Region
    • 3.5.2 Asia Pacific Synthetic Peptide Vaccine Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Synthetic Peptide Vaccine Market Facts & Figures by Country
    • 3.6.1 Latin America Synthetic Peptide Vaccine Sales by Country
    • 3.6.2 Latin America Synthetic Peptide Vaccine Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Synthetic Peptide Vaccine Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Synthetic Peptide Vaccine Sales by Country
    • 3.7.2 Middle East and Africa Synthetic Peptide Vaccine Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Synthetic Peptide Vaccine Historic Market Analysis by Type

  • 4.1 Global Synthetic Peptide Vaccine Sales Market Share by Type (2016-2021)
  • 4.2 Global Synthetic Peptide Vaccine Revenue Market Share by Type (2016-2021)
  • 4.3 Global Synthetic Peptide Vaccine Price by Type (2016-2021)

5 Global Synthetic Peptide Vaccine Historic Market Analysis by Application

  • 5.1 Global Synthetic Peptide Vaccine Sales Market Share by Application (2016-2021)
  • 5.2 Global Synthetic Peptide Vaccine Revenue Market Share by Application (2016-2021)
  • 5.3 Global Synthetic Peptide Vaccine Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Anergis
    • 6.1.1 Anergis Corporation Information
    • 6.1.2 Anergis Description and Business Overview
    • 6.1.3 Anergis Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Anergis Synthetic Peptide Vaccine Product Portfolio
    • 6.1.5 Anergis Recent Developments/Updates
  • 6.2 Antigen Express
    • 6.2.1 Antigen Express Corporation Information
    • 6.2.2 Antigen Express Description and Business Overview
    • 6.2.3 Antigen Express Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Antigen Express Synthetic Peptide Vaccine Product Portfolio
    • 6.2.5 Antigen Express Recent Developments/Updates
  • 6.3 Apitope Technology
    • 6.3.1 Apitope Technology Corporation Information
    • 6.3.2 Apitope Technology Description and Business Overview
    • 6.3.3 Apitope Technology Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Apitope Technology Synthetic Peptide Vaccine Product Portfolio
    • 6.3.5 Apitope Technology Recent Developments/Updates
  • 6.4 Artificial Cell Technologies
    • 6.4.1 Artificial Cell Technologies Corporation Information
    • 6.4.2 Artificial Cell Technologies Description and Business Overview
    • 6.4.3 Artificial Cell Technologies Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Artificial Cell Technologies Synthetic Peptide Vaccine Product Portfolio
    • 6.4.5 Artificial Cell Technologies Recent Developments/Updates
  • 6.5 Benovus Bio
    • 6.5.1 Benovus Bio Corporation Information
    • 6.5.2 Benovus Bio Description and Business Overview
    • 6.5.3 Benovus Bio Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Benovus Bio Synthetic Peptide Vaccine Product Portfolio
    • 6.5.5 Benovus Bio Recent Developments/Updates
  • 6.6 Celgene Corporation
    • 6.6.1 Celgene Corporation Corporation Information
    • 6.6.2 Celgene Corporation Description and Business Overview
    • 6.6.3 Celgene Corporation Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Celgene Corporation Synthetic Peptide Vaccine Product Portfolio
    • 6.6.5 Celgene Corporation Recent Developments/Updates
  • 6.7 Immatics biotechnologies
    • 6.6.1 Immatics biotechnologies Corporation Information
    • 6.6.2 Immatics biotechnologies Description and Business Overview
    • 6.6.3 Immatics biotechnologies Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Immatics biotechnologies Synthetic Peptide Vaccine Product Portfolio
    • 6.7.5 Immatics biotechnologies Recent Developments/Updates
  • 6.8 Merck
    • 6.8.1 Merck Corporation Information
    • 6.8.2 Merck Description and Business Overview
    • 6.8.3 Merck Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Merck Synthetic Peptide Vaccine Product Portfolio
    • 6.8.5 Merck Recent Developments/Updates
  • 6.9 ImmunoCellular Therapeutics
    • 6.9.1 ImmunoCellular Therapeutics Corporation Information
    • 6.9.2 ImmunoCellular Therapeutics Description and Business Overview
    • 6.9.3 ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 ImmunoCellular Therapeutics Synthetic Peptide Vaccine Product Portfolio
    • 6.9.5 ImmunoCellular Therapeutics Recent Developments/Updates
  • 6.10 ISA Pharmaceuticals
    • 6.10.1 ISA Pharmaceuticals Corporation Information
    • 6.10.2 ISA Pharmaceuticals Description and Business Overview
    • 6.10.3 ISA Pharmaceuticals Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 ISA Pharmaceuticals Synthetic Peptide Vaccine Product Portfolio
    • 6.10.5 ISA Pharmaceuticals Recent Developments/Updates
  • 6.11 Lytix Biopharma
    • 6.11.1 Lytix Biopharma Corporation Information
    • 6.11.2 Lytix Biopharma Synthetic Peptide Vaccine Description and Business Overview
    • 6.11.3 Lytix Biopharma Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Lytix Biopharma Synthetic Peptide Vaccine Product Portfolio
    • 6.11.5 Lytix Biopharma Recent Developments/Updates
  • 6.12 Spotlight Innovation
    • 6.12.1 Spotlight Innovation Corporation Information
    • 6.12.2 Spotlight Innovation Synthetic Peptide Vaccine Description and Business Overview
    • 6.12.3 Spotlight Innovation Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Spotlight Innovation Synthetic Peptide Vaccine Product Portfolio
    • 6.12.5 Spotlight Innovation Recent Developments/Updates
  • 6.13 OncoTherapy Science
    • 6.13.1 OncoTherapy Science Corporation Information
    • 6.13.2 OncoTherapy Science Synthetic Peptide Vaccine Description and Business Overview
    • 6.13.3 OncoTherapy Science Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 OncoTherapy Science Synthetic Peptide Vaccine Product Portfolio
    • 6.13.5 OncoTherapy Science Recent Developments/Updates
  • 6.14 Peptech
    • 6.14.1 Peptech Corporation Information
    • 6.14.2 Peptech Synthetic Peptide Vaccine Description and Business Overview
    • 6.14.3 Peptech Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Peptech Synthetic Peptide Vaccine Product Portfolio
    • 6.14.5 Peptech Recent Developments/Updates
  • 6.15 Pharmasyntez
    • 6.15.1 Pharmasyntez Corporation Information
    • 6.15.2 Pharmasyntez Synthetic Peptide Vaccine Description and Business Overview
    • 6.15.3 Pharmasyntez Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Pharmasyntez Synthetic Peptide Vaccine Product Portfolio
    • 6.15.5 Pharmasyntez Recent Developments/Updates
  • 6.16 Sumitomo Dainippon Pharma
    • 6.16.1 Sumitomo Dainippon Pharma Corporation Information
    • 6.16.2 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Description and Business Overview
    • 6.16.3 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Product Portfolio
    • 6.16.5 Sumitomo Dainippon Pharma Recent Developments/Updates
  • 6.17 TapImmune
    • 6.17.1 TapImmune Corporation Information
    • 6.17.2 TapImmune Synthetic Peptide Vaccine Description and Business Overview
    • 6.17.3 TapImmune Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 TapImmune Synthetic Peptide Vaccine Product Portfolio
    • 6.17.5 TapImmune Recent Developments/Updates
  • 6.18 Targovax
    • 6.18.1 Targovax Corporation Information
    • 6.18.2 Targovax Synthetic Peptide Vaccine Description and Business Overview
    • 6.18.3 Targovax Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Targovax Synthetic Peptide Vaccine Product Portfolio
    • 6.18.5 Targovax Recent Developments/Updates

7 Synthetic Peptide Vaccine Manufacturing Cost Analysis

  • 7.1 Synthetic Peptide Vaccine Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Synthetic Peptide Vaccine
  • 7.4 Synthetic Peptide Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Synthetic Peptide Vaccine Distributors List
  • 8.3 Synthetic Peptide Vaccine Customers

9 Synthetic Peptide Vaccine Market Dynamics

  • 9.1 Synthetic Peptide Vaccine Industry Trends
  • 9.2 Synthetic Peptide Vaccine Growth Drivers
  • 9.3 Synthetic Peptide Vaccine Market Challenges
  • 9.4 Synthetic Peptide Vaccine Market Restraints

10 Global Market Forecast

  • 10.1 Synthetic Peptide Vaccine Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Synthetic Peptide Vaccine by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Synthetic Peptide Vaccine by Type (2022-2027)
  • 10.2 Synthetic Peptide Vaccine Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Synthetic Peptide Vaccine by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Synthetic Peptide Vaccine by Application (2022-2027)
  • 10.3 Synthetic Peptide Vaccine Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Synthetic Peptide Vaccine by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Synthetic Peptide Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Solution Phase Synthesis (SPS)
    Solid Phase Peptide Synthesis (SPPS)

    Segment by Application
    Prostate Cancer
    Breast Cancer
    Gastric Cancer
    Lung Cancer
    Pancreatic Cancer
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Anergis
    Antigen Express
    Apitope Technology
    Artificial Cell Technologies
    Benovus Bio
    Celgene Corporation
    Immatics biotechnologies
    Merck
    ImmunoCellular Therapeutics
    ISA Pharmaceuticals
    Lytix Biopharma
    Spotlight Innovation
    OncoTherapy Science
    Peptech
    Pharmasyntez
    Sumitomo Dainippon Pharma
    TapImmune
    Targovax

    Buy now